Geoffrey Seiler has positions in Salesforce and UiPath. The Motley Fool has positions in and recommends International ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus ...

Quick Summary ChatGPT thinks UiPath stock could drift lower over the next 60 days, projecting a move toward roughly $16.20 by late March as technical momentum weakens. Investors looking to express ...

UiPath’s PATH stock rebound reflects rising confidence in its strengthening fundamentals and long-term AI automation ...

UiPath (PATH) closed at $14.79 in the latest trading session, marking a -3.77% move from the prior day. This change lagged the S&P 500's daily gain of 0.26%. Elsewhere, the Dow gained 0.6%, while the ...

Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath (NYSE: PATH) defied critics in ...

Model Context Protocol-based agentic integration allows for faster, more accurate access and usage of data and information to reduce errors and elevate productivity ...

Alphabet, Salesforce, and UiPath all look like good buys right now. Tech stocks continue to lead the market higher, but that ...

The strong performance in artificial intelligence (AI) stocks in recent years has largely been led by big technology ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

UiPath (PATH) has been in focus after CEO Daniel Dines disclosed share sales under a pre arranged trading plan at the same ...